Apolipoprotein A1
Apolipoprotein A1 has been studied in 3 papers since 2023: 3 observational studies in people; 1 in the past year. The newest paper, Jun 17, 2026: “Association of the apolipoproteins with retinal arteriosclerosis in a health examination population”.
3 papers study it1 findingUpdated
See all 3 papers on apolipoprotein A1
At a glance
The findings reach people, from one lab or study. 1 lab in 1 country.
Humans: a single group. Cells, worms or flies and mice: nothing yet.
- 1 lab in 1 country
- Funder: Science and Technology Commission of Shanghai Municipality
- Humans3
What did studies of apolipoprotein A1 find?
1Studies of apolipoprotein A1 measured 1 outcome; the most studied are presbycusis (1 study).
Presbycusis
no changein humans1OR 0.864
1 study
Presbycusis
no changein humans1OR 0.864
Apolipoprotein A1 was not clearly linked with presbycusis in humans (Mendelian randomization, five methods) (OR 0.864, p = .061).
“APOA1L OR = 0.864, p = .061”
HumansMendelian randomization, five methods
Hearing research
Latest
1 paper in 12 monthsFrontiers in Cardiovascular Medicine
Association of the apolipoproteins with retinal arteriosclerosis in a health examination population
Cross-sectional study of 4,938 peopleBiomarkers
Hearing Research
No causal relationship serum lipids on age-related hearing loss based on Mendelian randomized evidence
Mendelian randomization in peopleEar
Calcified Tissue International
Lipid Metabolism, Methylation Aberrant, and Osteoporosis: A Multi-omics Study Based on Mendelian Randomization
Mendelian randomization in peopleDNA methylation